EU Medtechs Keep Open Mind On HTA Options In Wider Market Access Plan

Health technology assessment for medtech products in Europe is a strictly national responsibility, but is there a case for an EU-wide HTA system that could improve medtech market access? MedTech Europe chief executive Serge Bernasconi shares his views with In Vivo.

More from Global Vision

More from In Vivo